Head-to-head · computed 2026-08-11
TMates vs Zealthy
TMates: TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife. Zealthy: Zealthy pairs a $135/month membership with compounded medication sold separately or in bundles: all-in ongoing costs run about $297/month semaglutide and $449/month tirzepatide bundled, or about $286 and $351 on three-month-supply pricing once the membership is counted.
Tirzepatide
| TMates | Zealthy | |
|---|---|---|
| All-in maintenance | $297/mo | $449/mo |
| Best plan rate | $167/mo | $351/mo |
| 12-month total | $2,004 | $5,388 |
| Status | Reported · 2026-07-14 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, TMates's $297 a month undercuts Zealthy's $449 by $152 a month at the 10 mg/wk maintenance basis — $1,824 across a year. TMates's figure is reported (captured 2026-07-14) and Zealthy's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
TMates's tirzepatide ladder runs $297 a month billed monthly, and $167 a month on a twelve-month plan. Zealthy's runs $449 a month billed monthly, and $351 a month on a three-month plan. On the twelve-month basis TMates's $2,004 beats Zealthy's $5,388 by $3,384 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| TMates | Zealthy | |
|---|---|---|
| All-in maintenance | $249/mo | $297/mo |
| Best plan rate | $158/mo | $286/mo |
| 12-month total | $1,896 | $3,564 |
| Status | Reported · 2026-07-14 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, TMates's $249 a month undercuts Zealthy's $297 by $48 a month at the 2.4 mg/wk maintenance basis — $576 across a year. TMates's figure is reported (captured 2026-07-14) and Zealthy's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
TMates's semaglutide ladder runs $249 a month billed monthly, and $158 a month on a twelve-month plan. Zealthy's runs $297 a month billed monthly, and $286 a month on a three-month plan. On the twelve-month basis TMates's $1,896 beats Zealthy's $3,564 by $1,668 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
TMates carries no membership fee against Zealthy's $135 a month — $1,620 a year of structural cost before any medication ships, which is why this site prices everything all-in. On verifiability, TMates names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Zealthy's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice.
Structure, side by side
TMates
- MembershipNone
- Dose policyStructured titration; medication and provider visits included in price
- Commitment12-month plan or month-to-month; substantial difference in rates
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
Zealthy
- Membership$135/mo
- Dose policyNot stated on captured materials
- CommitmentMonthly membership; medication discounts require 3-month supply purchases
- CancellationPer published terms; membership and medication bill separately on unbundled plans — confirm both at checkout
- PharmacyPartner compounding pharmacies (NABP-accredited and LegitScript-certified per co
What our desk is watching on each
TMates: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Zealthy: The advertised $151 (semaglutide) and $216 (tirzepatide) figures are three-month-supply medication-only rates that exclude the $135 monthly membership — the canonical case for this site's all-in accounting. Bundled ongoing rates: $297/mo semaglutide, $449/mo tirzepatide after discounted first months ($217/$349). Brand-name pens run ~$1,349 cash through the platform. Reported from third-party reviews and Zealthy's own pricing page; our checkout capture is pending.
Questions people ask
Is TMates or Zealthy cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does TMates vs Zealthy miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do TMates and Zealthy cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,004 at TMates and $5,388 at Zealthy — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: TMates · Zealthy. Official sites: TMates ↗ · Zealthy ↗. Nothing here is medical advice.